Scientific Journal of Frontier Chemical Development since Feb 2013
Editorial board member
MicroLab Horizon - Charlottesville, Virginia Area since Aug 2012
Scientist
University of Virginia Jun 2009 - Aug 2012
Graduate Research Assistant
University of Virginia Sep 2008 - May 2009
Graduate Teaching Assistant
University of Minnesota Sep 2006 - May 2008
Graduate Teaching Assistant
Education:
University of Virginia 2008 - 2012
Doctor of Philosophy (Ph.D.), Analytical Chemistry
University of Minnesota-Twin Cities 2006 - 2008
Master of Science (M.S.), Materials Chemistry
Tianjin University 2002 - 2006
Bachelor of Science (B.S.), Chemistry
Skills:
Chemistry Biotechnology Analytical Chemistry Mass Spectrometry Organic Chemistry Microfluidics Materials Science Laboratory Nmr Pcr Uv/Vis Nanotechnology Xps Genetics Assay Development Uv/Vis Spectroscopy Surface Chemistry Mathematica Image Analysis Electrophoresis Dna Extraction Polymerase Chain Reaction Laboratory Skills Statistical Data Analysis Fluorescence Microscopy Purification Fluorescence Research Science
Interests:
Microarray Entrepreneurship Microfluidics Biotechnology New Technologies Photography Sports Chemistry
Hospira
Senior Scientist
Pfizer
Senior Scientist
Innopharma Jan 2011 - Sep 2014
Research Scientist
Celgene Coporation Apr 2002 - Jul 2009
Senior Research Scientist
Celgene Coporation May 1998 - Apr 2002
Research Scientist
Education:
University of Alberta 1991 - 1995
Doctorates, Doctor of Philosophy, Philosophy, Chemistry
Shandong Medical University
Masters, Chemistry
Shandong University, China
Bachelors, Chemistry
James P. Landers - Charlottesville VA, US Kimberly A. Kelly - Crozet VA, US Jingyi Li - Charlottesville VA, US Daniel C. Leslie - Brookline MA, US
Assignee:
University of Virginia Patent Foundation - Charlottesville VA
International Classification:
C12Q 1/68 C12Q 1/70
US Classification:
435 5, 435 612, 435 61, 435 611
Abstract:
The invention provides methods to detect or determine the presence or amount of a pathogen, such as a virus or bacterium, in a sample or the amount of cells based on the detection of their genomic DNA. The method employs magnetic substrates and subjects the sample and the magnetic substrate to forms of energy so as to induce aggregate formation and detects the aggregates.
James P. Landers - Charlottesville VA, US Jingyi Li - Charlottesville VA, US Daniel C. Leslie - Brookline MA, US
Assignee:
University of Virginia Patent Foundation - Charlottesville VA
International Classification:
C40B 30/00 C12Q 1/68
US Classification:
506 7, 435 61, 435 612
Abstract:
The invention provides methods to detect or quantify cells such as nucleated cells in a sample such as a physiological sample, which employ magnetic substrates and subjects the sample and the magnetic substrate to forms of energy so as to induce aggregate formation.
Method And System For Sample Collection, Storage, Preparation And Detection
- Southampton, GB Christopher Birch - Charlottesville VA, US Daniel Mills - Charlottesville VA, US Brian Root - Charlottesville VA, US James Landers - Charlottesville VA, US Jingyi Li - Charlottesville VA, US Matthew Yeung - Mount Waverley, AU David Saul - Dunedin, AU David Vigil - Mount Waverley, AU Andrew Guy - Mount Waverley, AU Stan Wada - Mount Waverley, AU Betina De Gorordo - Mount Waverley, AU Steward Dodman - Mount Waverley, AU Tom Moran - Southampton, GB Stuart Knowles - Mount Waverley, AU Fernando Dias - Mount Waverley, AU Rick Gardner - Mount Waverley, AU
A collection device for a biological sample to capture target compounds such as viruses or other pathogens or particles for testing from within the sample and move the captured target compound to a separate chamber for subsequent processing. The collection device can include an openable substance blister including capture particles located in a cup interior. Capture particles can attract and bind the target compounds from the sample. An extraction tube extracts any nucleic acid from the target compound for storage or subsequent amplification and testing to confirm presence of known microorganisms. The extraction tube can comprise a heat-deformable material and can be connected to a microfluidic cartridge for further processing of nucleic acid including, amplification and detection. The microfluidic cartridge includes valves and a plurality of chambers for amplification.
- Charlottesville VA, US Kimberly Renee JACKSON - Atlanta GA, US Daniel MILLS - Charlottesville VA, US Gavin T. GARNER - Charlottesville VA, US Jacquelyn A. DuVall - Raleigh NC, US Jingyi LI - Charlottesville VA, US
This disclosure provides for apparatuses, systems and methods for in vitro sample detection. For example in one embodiment, this disclosure provides an automated Pe-toner microfluidic device (and related method) on a centrifugal platform for DNA sample lysis and DNA extraction. A second embodiment provides a system and method for qualitative detection, quantification, and real-time monitoring of nucleic acid amplification products using magnetic bead aggregation inhibition. A third embodiment provides a platform for simultaneous detection of mRNA markers from blood, cell-free semen, sperm, saliva, and vaginal fluid. The third embodiment comprises a system and method that provide for simple, rapid, and fluorescence-free detection of body fluids using mRNA marker amplification and optical detection for mRNA marker analysis with a smart phone with image analysis.
Devices And Methods For Extraction, Separation And Thermocycling
- Charlottesville VA, US Jacquelyn A. DuVall - Raleigh NC, US Delphine Le Roux - Barboursville VA, US Brian Root - Charlottesville VA, US Daniel MIlls - Charlottesville VA, US Daniel A. Nelson - Charlottesville VA, US An-chi Tsuei - Charlottesville VA, US Brandon L. Thompson - Charlottesville VA, US Jingyi Li - Charlottesville VA, US Christopher Birch - Charlottesville VA, US
International Classification:
B01L 3/00 B01L 7/00 G01N 27/447
Abstract:
A method to extract, amplify and separate nucleic acid in a microfluidic device having a plurality of chambers and channels can include a) introducing cells having nucleic acid to a first chamber of the microfluidic device and subjecting the cells in the first chamber to conditions that lyse the cells. The method can further include b) subjecting the first chamber to centrifugal force, thereby allowing the lysate or a portion thereof having nucleic acid to be distributed to a second chamber through a first channel in the microfluidic device. The method can also include c) combining the lysate or the portion thereof and reagents for amplification of the nucleic acid, thereby providing a second mixture. The method can also include d) subjecting the second chamber to centrifugal force, thereby allowing gas to be expelled from the second mixture.
James P. Landers - Charlottesville VA, US Yiwen Ouyang - Charlottesville VA, US Jingyi Li - Charlottesville VA, US
International Classification:
B01L 3/00 B32B 38/00 B32B 38/10 B32B 37/18
US Classification:
436180, 422503, 156182
Abstract:
A microfluidic device having a chip defining fluid channels and having toner patches printed within the channels. The toner patches are printed with hydrophobic toner to apply inertial pressure to fluids travelling through the channels. The density of hydrophobic toner and the dimensions of the toner patch can be varied to alter the inertial pressure applied to the fluid. The chip can be rotated about a rotational axis to apply external pressure to fluids sufficient to overcome the inertial pressure created by the toner patch to push fluid past the toner patch. The rotational speed of the chip can be varied to facilitate movement of fluid through the channels and to push fluid past the hydrophobic toner patches.